Geneva – A new, open, transparent sublicence agreement between the Medicines Patent Pool (MPP) on behalf of C-TAP, and South African pharmaceutical company Biotech Africa will accelerate the manufacture and sale of a COVID-19 serological antibody technology around the world. The World Health Organization welcomes the sublicence agreement, the first of its kind to be … Continue reading New agreement under C-TAP aims to improve global access to COVID-19 testing technologies